These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 1844824

  • 1. [Nucleolar organizers in superficial bladder tumors. Prognostic analysis of 37 observations].
    Clement T, Visseaux-Coletto B, Adnet JJ, Ploton D, Lardennois B.
    Prog Urol; 1991 Apr; 1(2):216-29. PubMed ID: 1844824
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Role of proliferative activity estimated by bromodeoxyuridine labeling index in determining predictive factors of recurrence in superficial intermediately malignant bladder tumors.
    Tachibana M, Miyakawa A, Nakamura K, Baba S, Murai M, Tazaki H.
    J Urol; 1996 Jul; 156(1):63-9. PubMed ID: 8648839
    [Abstract] [Full Text] [Related]

  • 10. An immunohistochemical and prognostic evaluation of cathepsin D expression in 105 bladder carcinomas.
    Dickinson AJ, Fox SB, Newcomb PV, Persad RA, Sibley GN, Harris AL.
    J Urol; 1995 Jul; 154(1):237-41. PubMed ID: 7776437
    [Abstract] [Full Text] [Related]

  • 11. Prognostic factors for primary superficial transitional cell carcinoma of the bladder: a retrospective cohort study.
    Yang TB, Zeng FH, Sun ZQ.
    Chin Med J (Engl); 2006 Nov 05; 119(21):1821-8. PubMed ID: 17097038
    [Abstract] [Full Text] [Related]

  • 12. [Alterations of nucleoli and nucleolar organizers in proliferative cystitis and transitional cell carcinoma of the urinary bladder].
    Romanenko AM, Nosov AT, Bazalitskaia SV, Sabri Abdel' Maliak S, Adne ZhZh.
    Arkh Patol; 1992 Nov 05; 54(7):14-20. PubMed ID: 1471934
    [Abstract] [Full Text] [Related]

  • 13. Nucleolar organizer region in transitional cell carcinoma of the bladder.
    Pisac VP, Krizanac S, Andelinović S.
    Acta Med Croatica; 1997 Nov 05; 51(2):83-6. PubMed ID: 9204592
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Decreasing of p27(Kip1)and cyclin E protein levels is associated with progression from superficial into invasive bladder cancer.
    Kamai T, Takagi K, Asami H, Ito Y, Oshima H, Yoshida KI.
    Br J Cancer; 2001 May 04; 84(9):1242-51. PubMed ID: 11336477
    [Abstract] [Full Text] [Related]

  • 18. Superficial (pT2a) and deep (pT2b) muscle invasion in pathological staging of bladder cancer following radical cystectomy.
    Yu RJ, Stein JP, Cai J, Miranda G, Groshen S, Skinner DG.
    J Urol; 2006 Aug 04; 176(2):493-8; discussion 498-9. PubMed ID: 16813876
    [Abstract] [Full Text] [Related]

  • 19. Cyclin D1 expression in transitional cell carcinoma of the bladder: correlation with p53, waf1, pRb and Ki67.
    Tut VM, Braithwaite KL, Angus B, Neal DE, Lunec J, Mellon JK.
    Br J Cancer; 2001 Jan 04; 84(2):270-5. PubMed ID: 11161387
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.